Our Members

EUCOPE represents small to mid-sized companies that support, invest and produce the innovative medicines and therapies of the future.

Our members supply cutting-edge treatments that improve and save the lives of millions of patients. As a recognized stakeholder, we work with the European Commission and European Medicines Agency (EMA) to improve and maintain Europe’s competitiveness within the global life sciences industry. so patients have greater and more equitable access to new treatments faster.

Learn more about the benefits of membership with EUCOPE.

The following companies are members of EUCOPE:

List of EUCOPE Members

Interested in becoming a member?

EUCOPE gives voice to small to medium-sized innovative companies active in the field of pharmaceuticals, biotechnologies, and medical technologies at the European level. Learn more about the benefits of membership with EUCOPE.

Benefits of membership

 
Through our membership of EUCOPE, we’ve been able to far more effectively understand, follow and contribute to areas important to our patients, our business and our industry sector.

Jazz Pharmaceuticals

Over the years, we have come to appreciate the quality of your support – both from a strategic and day-to-day, tactical perspective – as well as the tailored attention that your leadership and staff continuously pay to any of your members, large or small, especially as you accomplish your mission of guiding us through often complex EU legislative processes and political decisions and of raising the attractiveness of Europe for our industry.

Ferring Pharmaceuticals

EUCOPE provides a platform for discussions on major healthcare topics and developments. Your ad hoc expertise on national market access issues, as well your close relationship with many national medicines and HTA agencies in Europe, are particularly useful for us, and I’m sure for many of the other members.

Circius Pharma

We believe that EUCOPE’s mission to facilitate trusted relationships with established stakeholders at the EU and national levels and giving greater voice to companies regardless of their size is very important to enabling innovation and the creation of synergies for the benefit of patients.

Norgine

What is unique about EUCOPE is that it provides the perfect mix of EU affairs and country perspectives. We appreciate EUCOPE’s willingness to explore new areas of engagement if it is important to its member companies as well as the swift and agile way it operates.

Organon

We see EUCOPE as an important advocate on policy issues for our industry in Brussels and a critical voice that represents small, medium, and global companies. Having EUCOPE champion the cutting-edge research and inherent risk-taking innovation required by our industry with policymakers helps to promote well-balanced policy proposals that allow all aspects of our industry to flourish. 

Amgen

As a specialized biotherapeutics company, we specifically value EUCOPE’s network and trusted relationships with established stakeholders at the EU and national levels to connect and share experiences with the European Commission, the European Parliament, Member States’ representatives, patient organizations, healthcare professionals and payers, academics, and other industry associations.

CSL Behring

EUCOPE’s successful intervention on behalf of its members and the broader life sciences industry with stakeholders spanning policymakers, payers, and influencers is unparalleled. MAP has proudly supported EUCOPE throughout our 10 years including many joint webinars and representation in payer meetings such as NICE, and we look forward to many more.

MAP Patient Access

One distinct feature of EUCOPE is its country and market access focus and expertise. Another one is its bottom-up approach and willingness to be innovation-driven before consensus-driven and allowing any of its members regardless of its size to bring forward an idea or project.

Alnylam